Neupogen (Filgrastim) Drug Information: Medication Guide and Patient Information

Pill Identifier Search

May 27, 2012

Neupogen

Hepatitis C »

Hepatitis C infection facts

HCV is one of several viruses that cause hepatitis (inflammation of the liver).
Up to 85% of individuals who are initially (acutely) infected with HCV will fail to eliminate the virus and will become chronically infected.
HCV is spread most commonly through inadvertent exposure to infected blood. Intravenous drug abuse is the most common mode of transmission. The risk of acquiring HCV through sexual contact is low.
Generally, patients do not develop symptoms of chronic infection with HCV until they have extensive scarring of the liver (cirrhosis). Some individuals, however, may have fatigue and other non-specific symptoms in the absence of cirrhosis. A minority of patients with HCV have symptoms from organs outside of the liver.
In the U.S., Infection with HCV is the most common cause of chronic hepatitis and the most common reason for liver transplantation.
...

Read the Hepatitis C article »

« Previous
1
2
3
4
5
6
7
8
9
10
11
12
13
Next »

Neupogen User Reviews >>

Neupogen

Breast Cancer Slideshow Pictures

Pancreatic Cancer Slideshow Pictures

Skin Cancer Slideshow Pictures

font size

PATIENT INFORMATION

Information for Patients and Caregivers

Patients should be referred to the "Information for Patients and Caregivers" labeling included with the package insert in each dispensing pack of NEUPOGEN® (filgrastim) vials or NEUPOGEN® (filgrastim) prefilled syringes. The "Information for Patients and Caregivers" labeling provides information about neutrophils and neutropenia and the safety and efficacy of NEUPOGEN® (filgrastim) . It is not intended to be a disclosure of all known or possible effects.

Last reviewed on RxList: 4/18/2008
This monograph has been modified to include the generic and brand name in many instances.